BRS6-4-8 - Adipose Endocrine Regulation
(Communicating Metabolic State Through Adipose Hormones)
1. Mission & Overview
Mission
Regulate adipose-derived endocrine signalling and local glucocorticoid responsiveness to communicate metabolic state and coordinate hormonal adaptation.
Intervention Dominance: Diet-Supported — No principal intervention route established
Evidence covers selected adipokine operations, not all receptor or local glucocorticoid functions. Energy balance, weight change, sex, depot and protocol remain material. No universal optimisation target or comparative superiority inferred; local cortisol regeneration and receptor responsiveness remain incompletely covered.
Overview
Adipose tissue communicates metabolic state through endocrine signals, including leptin and adiponectin. Hormone synthesis, release and target responsiveness respond to metabolic and hormonal conditions. Local cortisone-to-cortisol regeneration and glucocorticoid receptors provide another level of regulation. These operations interact, but they do not establish one universal causal chain: circulating hormone levels, tissue secretion and stress feedback require different measurements. [27]; [28]
- Biological function: Distinct adipokines communicate with other tissues through their receptors; production and circulating concentration are not interchangeable. [27]
- Local regulation: Human tissue studies distinguish hormone synthesis and secretion, while local cortisol conversion differs from systemic metabolism. [30]; [29]
- Brain relevance: Mouse adipocyte-GR experiments support stress-feedback involvement; the mediator and corresponding human pathway remain unresolved. [25]
2. Primary Biological Effects
- Context-dependent leptin and adiponectin output rather than universal increases or suppression. [30]; [31]
- Local glucocorticoid availability and cellular responsiveness, distinct from systemic cortisol rhythm. [29]
- A qualified peripheral contribution to stress feedback demonstrated in a genetic mouse model. [25]
3. Intervention Levers
- DHA
No canonical cofactor/substrate mapping established.
No shared-resource relationship is currently admitted. Earlier KC questions remain accessible in Evidence & Audit.
- Hypocaloric dietary weight-loss programme in adults with obesity
- Milled flaxseed in the studied balanced-diet protocol
- Aerobic exercise with context-specific adipose endocrine responses
4. Mechanistic Basis + Scientific Findings (SFs 10)
Summary
Hormone production, release and local cortisol regeneration allow adipose tissue to respond to metabolic and hormonal conditions. These control points are related, but a change in a blood hormone concentration does not by itself identify which tissue process changed. [30]; [29]
- Adipokine production and release: synthesis, storage and secretion respond differently, with hormone- and depot-specific effects (SF12).
- Local cortisol regulation: adipose cortisol regeneration differs from whole-body metabolism; enzyme expression and activity are separate endpoints (SF13).
- Stress feedback: adipocyte glucocorticoid receptors contribute to feedback in mice, while the mediator and equivalent human pathway remain unresolved (SF14).
- Energy balance and activity: circulating responses, local hormone release during weight reduction and exercise-related tissue responses require different interpretations (SF15, SF16, SF17).
- EPA and DHA: cultured-cell secretion and circulating responses to oral formulations establish different parts of the evidence (SF18, SF19).
- Flaxseed and soluble fibre: a food-specific trial signal and pooled null findings constrain generalisation (SF20, SF21).
SF12 — Adipokine responses depend on hormone, depot and exposure
Human adipose pulse-labelling separates leptin biosynthesis from release of stored protein. Dexamethasone can increase leptin synthesis while suppressing adiponectin release in other preparations; these are distinct hormone-specific responses. Circulating adiponectin responses to systemic glucocorticoids are not uniformly reproduced. [30]; [31]; [36]; [38]
Supporting evidence: SF12 — Adipokine responses depend on hormone, depot and exposure. Foundational hormone identities: PM8-SP2.
SF13 — Local adipose cortisol regeneration differs from systemic metabolism
Microdialysis and tracer measurements distinguish local cortisone-to-cortisol conversion from systemic turnover. Insulin effects differed by adiposity. A low-carbohydrate crossover altered systemic cortisol metabolism without a measured adipose 11β-HSD1 response. Weight-loss studies reported different directions of adipose transcript change: an increase in one small study and decreases at six and 24 months in another. Neither transcript direction establishes a matching change in local cortisol regeneration. [29]; [32]; [33]; [48]
Supporting evidence: SF13 — Local adipose cortisol regeneration differs from systemic metabolism. Established reaction provenance: PM8-SP1 — 11β-HSD1.
SF14 — Adipocyte glucocorticoid-receptor reduction changes mouse stress feedback
The genetic experiment supports a qualified contribution of adipocyte-enriched GR signalling to mouse stress feedback. The communicating signal was not identified; unchanged baseline adipokines do not establish an adipokine-mediated pathway. Human stress feedback through the same route remains unresolved. [25]
Supporting evidence: SF14 — Adipocyte glucocorticoid-receptor reduction changes mouse stress feedback.
SF15 — Diet and activity outcomes distinguish circulating hormones from local production
Alternate-day and daily energy restriction reduced circulating leptin without an adiponectin change in one randomised trial. POUNDS Lost reported increased circulating adiponectin over two years across diet groups. A small walking trial increased adipose adiponectin mRNA without a significant plasma increase. Duration, tissue measurement and circulating exposure must remain separate. [34]; [35]; [37]
Supporting evidence: SF15 — Diet and activity outcomes distinguish circulating hormones from local production.
SF16 — Dietary weight-reduction programmes alter local adipokine release within studied contexts
Energy deficit and weight reduction can alter adipose hormone release. Hypocaloric programmes in women with obesity reduced measured leptin release, while adiponectin responses differed by depot and phase or remained unchanged. Energy deficit, weight loss and accompanying changes cannot be fully separated in these results. [39]; [40]; [41]
Supporting evidence: SF16 — Dietary weight-reduction programmes alter local adipokine release within studied contexts.
SF17 — Aerobic exercise engages local adipokine regulation with compartment-specific and null responses
Exercise can change the local adipose endocrine environment without producing the same change in circulating hormones. Human studies measured acute interstitial adiponectin changes and training-related gene-expression responses, alongside null tissue findings in another population. Interstitial concentration is not secretion rate, and messenger RNA is not released protein. [43]; [44]; [45]
Supporting evidence: SF17 — Aerobic exercise engages local adipokine regulation with compartment-specific and null responses.
SF18 — EPA/DHA adipocyte secretion effects do not establish equivalent food delivery
Defined EPA and DHA exposures increased adiponectin secretion in cultured human adipocytes. Oral fish-oil trials measured heterogeneous circulating responses; they do not establish that ordinary foods reproduce the cultured-cell exposure or secretory mechanism. [46]; [47]
Supporting evidence: SF18 — EPA/DHA adipocyte secretion effects do not establish equivalent food delivery.
SF19 — DHA formulations can alter circulating adiponectin in defined human contexts
Selected oral DHA formulations changed circulating adiponectin in human interventions. Mixed marine-omega-3 and DHA-enriched-oil studies provide related but formulation-specific evidence. Adipose fatty-acid incorporation and a blood hormone response do not establish altered local secretion, receptor sensitivity or equivalent effects from ordinary fish intake. [68]; [64]; [65]; [63]
Supporting evidence: SF19 — DHA formulations can alter circulating adiponectin in defined human contexts.
SF20 — Milled flaxseed has a bounded circulating adiponectin trial signal
A milled-flaxseed intervention reported a circulating adiponectin difference in overweight or obese women. The broader pooled evidence was heterogeneous and did not establish an overall adiponectin effect. The food-specific result does not identify ALA, lignans or fibre as the causal constituent, nor establish weight-independent mediation or altered adipose secretion. [66]; [69]
Supporting evidence: SF20 — Milled flaxseed has a bounded circulating adiponectin trial signal.
SF21 — Soluble-fibre pooled adipokine evidence does not establish a generic endocrine intervention
Pooled soluble-fibre trials did not establish significant overall changes in circulating leptin or adiponectin and showed substantial heterogeneity. This limits a generic soluble-fibre endocrine claim; it does not establish the absence of every preparation-specific effect or identify a local adipose mechanism. [67]
Supporting evidence: SF21 — Soluble-fibre pooled adipokine evidence does not establish a generic endocrine intervention.
(Boundaries of the mechanism)
Adipokine output and local adipose glucocorticoid regulation are distinct from insulin-responsive glucose disposal, systemic cortisol timing and central stress-modulated appetite and reward. Inflammatory activation and resolution remain within BRS3. Reduced fat-depot size alone is not an endocrine endpoint.
(Integration within BRS6)
Adipose endocrine output provides the peripheral component of metabolic–endocrine signalling and adaptive regulation. PM9 addresses central appetite and reward responses. No shared Key Constraint relationship is currently admitted; this placement does not establish a single adipokine–glucocorticoid–brain causal chain.
4.1 Scientific Findings (10)
Summary
Human tissue, local cortisol and mouse stress-feedback evidence address distinct endocrine operations. Intervention measurements do not establish a single adipokine–glucocorticoid–brain causal chain.
Not scored · Evidence & Audit
Insulin and glucocorticoid exposures regulate leptin synthesis or release and adiponectin expression or release in human adipose preparations, with context-dependent responses.
What this means
Human adipose pulse-labelling separates leptin biosynthesis from release of stored protein. Dexamethasone can increase leptin synthesis while suppressing adiponectin release in other preparations; these are distinct hormone-specific responses. Circulating adiponectin responses to systemic glucocorticoids are not uniformly reproduced.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F12
Finding Statement: Insulin and glucocorticoid exposures regulate leptin synthesis or release and adiponectin expression or release in human adipose preparations, with context-dependent responses.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: Human adipose pulse-labelling separates leptin biosynthesis from release of stored protein. Dexamethasone can increase leptin synthesis while suppressing adiponectin release in other preparations; these are distinct hormone-specific responses. Circulating adiponectin responses to systemic glucocorticoids are not uniformly reproduced.
Synthesis Limitations: Ex vivo hormone exposures and pharmacological glucocorticoids do not establish ordinary dietary effects. Donor adiposity, depot, exposure duration and concentration matter; circulating concentrations do not measure secretion rates or receptor sensitivity.
Evidence Considered:
- Study
- Human adipose organ culture; acute versus 1–2-day insulin/dexamethasone exposure and metabolic pulse-chase labelling.
- Population
- Human adipose organ culture; acute versus 1–2-day insulin/dexamethasone exposure and metabolic pulse-chase labelling.
- Result
- Chronic insulin increased leptin biosynthesis without a matching mRNA rise; dexamethasone increased mRNA and biosynthesis. Acute insulin increased release of labelled preformed leptin.
- Effect / Magnitude
- Abstract reports nearly doubled labelled leptin release after a one-hour chase; no exact uncertainty recovered.
- Evidence Summary
- Chronic insulin increased leptin biosynthesis without a matching mRNA rise; dexamethasone increased mRNA and biosynthesis. Acute insulin increased release of labelled preformed leptin.
- Limitations
- Ex vivo exposure; donor and assay-level bias/precision require full-method appraisal. No food comparison.
- Evidence Source
- Bounded external search
- Reference
- [30]
- Study
- Isolated human subcutaneous and omental adipocytes, with dexamethasone and TNFα incubation.
- Population
- Isolated human subcutaneous and omental adipocytes, with dexamethasone and TNFα incubation.
- Result
- Dexamethasone inhibited adiponectin release after 24 hours; TNFα response varied with donor adiposity and depot.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Dexamethasone inhibited adiponectin release after 24 hours; TNFα response varied with donor adiposity and depot.
- Limitations
- Cross-sectional donor comparisons and cultured-cell hormone exposure; mRNA is not secreted protein and depot responses differ.
- Evidence Source
- Bounded external search
- Reference
- [31]
- Study
- Acute intravenous hydrocortisone in five healthy volunteers plus matched comparisons in Cushing’s syndrome.
- Population
- Acute intravenous hydrocortisone in five healthy volunteers plus matched comparisons in Cushing’s syndrome.
- Result
- Circulating adiponectin decreased acutely; non-obese but not obese Cushing’s comparisons differed.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Circulating adiponectin decreased acutely; non-obese but not obese Cushing’s comparisons differed.
- Limitations
- Small pharmacological challenge; plasma concentration and disease comparisons do not identify secretion flux.
- Evidence Source
- Bounded external search
- Reference
- [36]
- Study
- Blinded placebo-controlled randomisation of 25 healthy men to five days of oral dexamethasone or placebo.
- Population
- Blinded placebo-controlled randomisation of 25 healthy men to five days of oral dexamethasone or placebo.
- Result
- No between-arm difference in mean changes in circulating leptin or adiponectin despite metabolic effects.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- No between-arm difference in mean changes in circulating leptin or adiponectin despite metabolic effects.
- Limitations
- Different duration, drug and population from the acute hydrocortisone study; null plasma response does not negate cultured-cell regulation.
- Evidence Source
- Bounded external search
- Reference
- [38]
Connected / Supportive Evidence:
- Scheja and Heeren (2019) [27] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
Mechanistic explanation: Adipokine responses depend on hormone, depot and exposure
Not scored · Evidence & Audit
Supports SOP: Hypocaloric dietary weight-loss programme in adults with obesity
Human adipose cortisol regeneration is tissue- and metabolic-context dependent; whole-body dietary changes in cortisol metabolism do not necessarily alter subcutaneous adipose 11β-HSD1.
What this means
Microdialysis and tracer measurements distinguish local cortisone-to-cortisol conversion from systemic turnover. Insulin effects differed by adiposity. A low-carbohydrate crossover altered systemic cortisol metabolism without a measured adipose 11β-HSD1 response; weight loss in another small study increased adipocyte transcript expression rather than demonstrating universal suppression.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F13
Finding Statement: Human adipose cortisol regeneration is tissue- and metabolic-context dependent; whole-body dietary changes in cortisol metabolism do not necessarily alter subcutaneous adipose 11β-HSD1.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: Microdialysis and tracer measurements distinguish local cortisone-to-cortisol conversion from systemic turnover. Insulin effects differed by adiposity. A low-carbohydrate crossover altered systemic cortisol metabolism without a measured adipose 11β-HSD1 response; weight loss in another small study increased adipocyte transcript expression rather than demonstrating universal suppression.
Synthesis Limitations: Small selected samples and differing assays; transcript abundance is not in vivo regeneration flux. Systemic or hepatic effects cannot be assigned to adipose, and less local cortisol activity is not assumed universally beneficial.
Evidence Considered:
- Study
- Six lean and six obese men; cortisol tracer, adipose microdialysis and carbenoxolone crossover in obese men.
- Population
- Six lean and six obese men; cortisol tracer, adipose microdialysis and carbenoxolone crossover in obese men.
- Result
- Adipose cortisone conversion was greater in obese men although whole-body regeneration did not differ. Insulin suppressed adipose activity in lean but not obese men; carbenoxolone did not significantly inhibit adipose activity or improve insulin sensitivity.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Adipose cortisone conversion was greater in obese men although whole-body regeneration did not differ. Insulin suppressed adipose activity in lean but not obese men; carbenoxolone did not significantly inhibit adipose activity or improve insulin sensitivity.
- Limitations
- Small male sample; non-selective pharmacology and distinct systemic versus local assays.
- Evidence Source
- Bounded external search
- Reference
- [29]
- Study
- Two randomised dietary crossover studies in obese men: 17 ad libitum participants and six in an isocaloric comparison.
- Population
- Two randomised dietary crossover studies in obese men: 17 ad libitum participants and six in an isocaloric comparison.
- Result
- Diet altered whole-body cortisol regeneration and clearance, but subcutaneous adipose 11β-HSD1 mRNA and activity were unaffected.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Diet altered whole-body cortisol regeneration and clearance, but subcutaneous adipose 11β-HSD1 mRNA and activity were unaffected.
- Limitations
- Four-week dietary exposures; no extrapolation to visceral depots, women, or a specific constituent.
- Evidence Source
- Bounded external search
- Reference
- [32]
- Study
- Before/after ten-week very-low-calorie diet in 12 adults with obesity.
- Population
- Before/after ten-week very-low-calorie diet in 12 adults with obesity.
- Result
- Adipocyte 11β-HSD1 mRNA increased after substantial weight loss.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Adipocyte 11β-HSD1 mRNA increased after substantial weight loss.
- Limitations
- No randomised control for this before/after comparison; expression is not secretion, receptor sensitivity or measured local flux.
- Evidence Source
- Bounded external search
- Reference
- [33]
- Study
- 49 postmenopausal women with overweight/obesity randomised to Paleolithic-type or Nordic-recommendation diets for 24 months.
- Population
- 49 postmenopausal women with overweight/obesity randomised to Paleolithic-type or Nordic-recommendation diets for 24 months.
- Result
- Adipose 11β-HSD1 mRNA decreased at 6 and 24 months while weight fell; hepatic conversion increased transiently at 6 months.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Adipose 11β-HSD1 mRNA decreased at 6 and 24 months while weight fell; hepatic conversion increased transiently at 6 months.
- Limitations
- Transcript is not local enzyme activity or cortisol-regeneration flux. Both diets produced weight loss; no independent effect of individual foods or weight-independent mechanism. Published 2015, online 2014.
- Evidence Source
- Bounded external search
- Reference
- [48]
Connected / Supportive Evidence:
- de Kloet and Herman (2018; online 2017) [26] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
- Scheja and Heeren (2019) [27] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
Mechanistic explanation: Local adipose cortisol regeneration differs from systemic metabolism
Not scored · Evidence & Audit
Reducing glucocorticoid-receptor expression in adiponectin-Cre mice increased restraint-related corticosterone responses and impaired dexamethasone feedback, without a detected baseline leptin or adiponectin difference.
What this means
The genetic experiment supports a qualified contribution of adipocyte-enriched GR signalling to mouse stress feedback. The communicating signal was not identified; unchanged baseline adipokines do not establish an adipokine-mediated pathway. Human stress feedback through the same route remains unresolved.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F14
Finding Statement: Reducing glucocorticoid-receptor expression in adiponectin-Cre mice increased restraint-related corticosterone responses and impaired dexamethasone feedback, without a detected baseline leptin or adiponectin difference.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: The genetic experiment supports a qualified contribution of adipocyte-enriched GR signalling to mouse stress feedback. The communicating signal was not identified; unchanged baseline adipokines do not establish an adipokine-mediated pathway. Human stress feedback through the same route remains unresolved.
Synthesis Limitations: Genetic mouse model, incomplete and depot-variable knockdown, possible untested off-target sites, and developmental effects. Baseline hormone concentrations do not exclude dynamic secretion changes. No human dietary, cognitive or ADHD effect is established.
Evidence Considered:
- Study
- Adiponectin-promoter Cre/lox GR knockdown and littermate controls; restraint, dexamethasone suppression, ACTH challenge, expression and circulating hormones.
- Population
- Adiponectin-promoter Cre/lox GR knockdown and littermate controls; restraint, dexamethasone suppression, ACTH challenge, expression and circulating hormones.
- Result
- Stress corticosterone increased and suppression was impaired; tested central/adrenal GR expression and adrenal ACTH responsiveness did not explain the result. Baseline leptin and adiponectin did not differ.
- Effect / Magnitude
- Male restraint AUC t(67)=4.614, p<0.01; dexamethasone experiment n=5/group. These are distinct comparisons, not independent replications.
- Evidence Summary
- Stress corticosterone increased and suppression was impaired; tested central/adrenal GR expression and adrenal ACTH responsiveness did not explain the result. Baseline leptin and adiponectin did not differ.
- Limitations
- Adiponectin-Cre specificity not exhaustive; knockdown varied by depot, mediator unresolved, and no human intervention.
- Evidence Source
- Bounded external search
- Reference
- [25]
Connected / Supportive Evidence:
- de Kloet and Herman (2018; online 2017) [26] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
- Tsuji and Tseng (2026) [28] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
Mechanistic explanation: Adipocyte glucocorticoid-receptor reduction changes mouse stress feedback
Not scored · Evidence & Audit
Dietary energy restriction and physical activity can change selected circulating adipokines or adipose transcripts, but these endpoints do not establish a uniform change in adipokine secretion or improved endocrine responsiveness.
What this means
Alternate-day and daily energy restriction reduced circulating leptin without an adiponectin change in one randomised trial. POUNDS Lost reported increased circulating adiponectin over two years across diet groups. A small walking trial increased adipose adiponectin mRNA without a significant plasma increase. Duration, tissue measurement and circulating exposure must remain separate.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F15
Finding Statement: Dietary energy restriction and physical activity can change selected circulating adipokines or adipose transcripts, but these endpoints do not establish a uniform change in adipokine secretion or improved endocrine responsiveness.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: Alternate-day and daily energy restriction reduced circulating leptin without an adiponectin change in one randomised trial. POUNDS Lost reported increased circulating adiponectin over two years across diet groups. A small walking trial increased adipose adiponectin mRNA without a significant plasma increase. Duration, tissue measurement and circulating exposure must remain separate.
Synthesis Limitations: These trials do not directly quantify adipose secretion or receptor sensitivity. Lower leptin or higher adiponectin is not automatically a better endocrine state. Selected populations, adherence and weight change limit translation; no optimal universal protocol or brain outcome is established.
Evidence Considered:
- Study
- Pre-planned secondary analysis of 100 adults randomised to alternate-day restriction, daily restriction or control for 24 weeks.
- Population
- Pre-planned secondary analysis of 100 adults randomised to alternate-day restriction, daily restriction or control for 24 weeks.
- Result
- Leptin decreased in both restriction groups; circulating adiponectin, resistin, IL-6 and TNFα did not change relative to control.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Leptin decreased in both restriction groups; circulating adiponectin, resistin, IL-6 and TNFα did not change relative to control.
- Limitations
- Secondary endpoints; circulating concentrations, not secretion or sensitivity. No superiority of alternate-day restriction.
- Evidence Source
- Bounded external search
- Reference
- [34]
- Study
- POUNDS Lost: 768 participants with baseline adiponectin among 811 adults randomised to four weight-loss diets; six-month and two-year measurements.
- Population
- POUNDS Lost: 768 participants with baseline adiponectin among 811 adults randomised to four weight-loss diets; six-month and two-year measurements.
- Result
- Circulating adiponectin increased over two years without a significant difference between diet groups.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Circulating adiponectin increased over two years without a significant difference between diet groups.
- Limitations
- No non-weight-loss control in this comparison; outcome associations do not prove adiponectin mediation or secretion change.
- Evidence Source
- Bounded external search
- Reference
- [35]
- Study
- Sixteen overweight/obese middle-aged men with type 2 diabetes randomised to 12 weeks of walking activity or control.
- Population
- Sixteen overweight/obese middle-aged men with type 2 diabetes randomised to 12 weeks of walking activity or control.
- Result
- Subcutaneous adiponectin mRNA increased but plasma adiponectin did not significantly change.
- Effect / Magnitude
- Direction and endpoint retained; no unverified effect size or uncertainty estimate supplied.
- Evidence Summary
- Subcutaneous adiponectin mRNA increased but plasma adiponectin did not significantly change.
- Limitations
- Eight participants per group; mRNA is not protein secretion. This does not establish an endocrine optimisation protocol for all adults.
- Evidence Source
- Bounded external search
- Reference
- [37]
Connected / Supportive Evidence:
- Scheja and Heeren (2019) [27] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
- Tsuji and Tseng (2026) [28] — ReviewWhy relevant: Secondary synthesis informs endocrine scope and discovery of primary evidence.Why excluded from the primary synthesis: Not an independent primary replication or evidence of dietary effectiveness.
· Provisionally assessed · Evidence & Audit
Supports SOP: Hypocaloric dietary weight-loss programme in adults with obesity
Hypocaloric weight-reduction programmes in women with obesity reduced ex vivo adipose leptin release, while adiponectin responses were depot-specific or unchanged.
What this means
Independent programmes measured adipose release rather than relying on circulating concentrations alone. You measured release in 27 of 42 women and found abdominal but not gluteal adiponectin increases. Arvidsson found lower leptin secretion without an adiponectin increase. Siklova shows that active restriction and stabilisation differ. Fasting and mixed-meal arteriovenous studies provide contextual evidence of acute local regulation, not equivalent weight-loss protocols.
Evidence confidence: · Provisionally assessed · Evidence & Audit
Finding ID: PM8-F16
Finding Statement: Hypocaloric weight-reduction programmes in women with obesity reduced ex vivo adipose leptin release, while adiponectin responses were depot-specific or unchanged.
Synthesised Evidence Confidence: · Provisionally assessed · Evidence & Audit
Synthesis: Independent programmes measured adipose release rather than relying on circulating concentrations alone. You measured release in 27 of 42 women and found abdominal but not gluteal adiponectin increases. Arvidsson found lower leptin secretion without an adiponectin increase. Siklova shows that active restriction and stabilisation differ. Fasting and mixed-meal arteriovenous studies provide contextual evidence of acute local regulation, not equivalent weight-loss protocols.
Synthesis Limitations: Energy deficit, weight loss and co-interventions are not fully separable. Ex vivo release, venous–arterial concentration difference, transcript and plasma measurements remain distinct. No universal optimal hormone direction, food attribution, brain benefit or weight-independent endocrine effect is established.
Evidence Considered:
- Study
- 42 older abdominally obese women; 20-week hypocaloric programme, with or without aerobic exercise; pooled pre/post analysis. Ex vivo release measured in 27 women.
- Population
- 42 older abdominally obese women; 20-week hypocaloric programme, with or without aerobic exercise; pooled pre/post analysis. Ex vivo release measured in 27 women.
- Result
- Weight loss 10.1 ± 0.7 kg. Leptin release decreased in both depots; adiponectin release increased only abdominally. Tissue and circulating changes were not significantly correlated.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Weight loss 10.1 ± 0.7 kg. Leptin release decreased in both depots; adiponectin release increased only abdominally. Tissue and circulating changes were not significantly correlated.
- Limitations
- Release subgroup n=27, expression n=42. No untreated comparator for pooled analysis; exercise could not be isolated. Whole-tissue ex vivo release is not in vivo flux. Population, depot, weight loss and energy balance constrain interpretation.
- Evidence Source
- Bounded external search
- Reference
- [39]
- Study
- 40 women with obesity randomised to 10-week hypocaloric low-fat/high-carbohydrate or moderate-fat/moderate-carbohydrate diets; deficit 600 kcal/day.
- Population
- 40 women with obesity randomised to 10-week hypocaloric low-fat/high-carbohydrate or moderate-fat/moderate-carbohydrate diets; deficit 600 kcal/day.
- Result
- Approximately 7.5% weight loss and 40% lower leptin secretion; adiponectin secretion unchanged. Diet arms had similar responses.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Approximately 7.5% weight loss and 40% lower leptin secretion; adiponectin secretion unchanged. Diet arms had similar responses.
- Limitations
- No weight-stable comparator; cannot separate energy deficit from weight loss. Adiponectin null qualifies You abdominal response; no macronutrient superiority. Tested deficit is a study exposure, not an effective-dose prescription.
- Evidence Source
- Bounded external search
- Reference
- [40]
- Study
- 48 women with obesity: 1-month very-low-calorie diet then 5 months stabilisation/maintenance; release subgroup 26, transcript subgroup 22.
- Population
- 48 women with obesity: 1-month very-low-calorie diet then 5 months stabilisation/maintenance; release subgroup 26, transcript subgroup 22.
- Result
- Adipocyte-produced leptin measures fell during very-low-calorie feeding and rose during stabilisation; stromavascular adipokines followed different patterns.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Adipocyte-produced leptin measures fell during very-low-calorie feeding and rose during stabilisation; stromavascular adipokines followed different patterns.
- Limitations
- Uncontrolled multiphase programme; cellular source and energy-balance phase matter. Does not justify sustained maximisation of leptin suppression or a general very-low-calorie diet recommendation.
- Evidence Source
- Bounded external search
- Reference
- [41]
- Study
- 9 lean and 9 upper-body obese women studied after 14 and 22 hours fasting.
- Population
- 9 lean and 9 upper-body obese women studied after 14 and 22 hours fasting.
- Result
- Release declined in lean women but changed little in women with upper-body obesity.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Release declined in lean women but changed little in women with upper-body obesity.
- Limitations
- Small acute physiology experiment; fasting duration, time of day and energy balance not independently isolated. Does not validate a fasting protocol or universal lower-leptin target.
- Evidence Source
- Bounded external search
- Reference
- [42]
- Study
- 6 volunteers: oral 40 g fat/9.6 g carbohydrate versus intravenous fat; separate 8 volunteers: mixed meal 37 g fat/100 g carbohydrate.
- Population
- 6 volunteers: oral 40 g fat/9.6 g carbohydrate versus intravenous fat; separate 8 volunteers: mixed meal 37 g fat/100 g carbohydrate.
- Result
- Leptin venous–arterial difference fell after fat loads and rose after the mixed meal, peaking at 240 minutes.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Leptin venous–arterial difference fell after fat loads and rose after the mixed meal, peaking at 240 minutes.
- Limitations
- Different small cohorts, non-isolated carbohydrate, oral versus intravenous exposure. Concentration difference is not equivalent to fully quantified secretion flux. No optimal meal or carbohydrate requirement established.
- Evidence Source
- Bounded external search
- Reference
- [49]
Not scored · Evidence & Audit
Supports Lifestyle Lever: Aerobic exercise with context-specific adipose endocrine responses
Aerobic exercise changed adipose interstitial adiponectin or adipokine transcripts in some human protocols, with null tissue or circulating responses in other studied populations.
What this means
Acute exercise increased local interstitial adiponectin while plasma stayed unchanged and mRNA decreased. A small training study increased adipose adiponectin mRNA; another training study found no changes in tested tissue transcripts. These are different measurements and contexts, not independent replications of one secretion-rate effect.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F17
Finding Statement: Aerobic exercise changed adipose interstitial adiponectin or adipokine transcripts in some human protocols, with null tissue or circulating responses in other studied populations.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: Acute exercise increased local interstitial adiponectin while plasma stayed unchanged and mRNA decreased. A small training study increased adipose adiponectin mRNA; another training study found no changes in tested tissue transcripts. These are different measurements and contexts, not independent replications of one secretion-rate effect.
Synthesis Limitations: Interstitial concentration is not secretion flux, and mRNA is not released protein. Training-related adiposity changes, small biopsy samples and sex/protocol differences limit generalisation. Neither an optimal exercise dose nor improved adipokine receptor sensitivity, brain function or clinical benefit is established.
Evidence Considered:
- Study
- 8 overweight and 8 lean men; rest comparison day versus 1 hour exercise at 55% VO2max with pre/post subcutaneous biopsy.
- Population
- 8 overweight and 8 lean men; rest comparison day versus 1 hour exercise at 55% VO2max with pre/post subcutaneous biopsy.
- Result
- Interstitial adiponectin increased despite unchanged plasma adiponectin and decreased adiponectin mRNA. Leptin mRNA decreased.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Interstitial adiponectin increased despite unchanged plasma adiponectin and decreased adiponectin mRNA. Leptin mRNA decreased.
- Limitations
- Interstitial concentration is not secretion rate; blood flow, recovery and compartment distribution matter. Acute small male sample does not define chronic response, receptor sensitivity or clinical benefit.
- Evidence Source
- Bounded external search
- Reference
- [43]
- Study
- 16 sedentary overweight/obese men randomised 8 training/8 control; 12 weeks, 4 days/week, 45 minutes at 75–80% VO2max.
- Population
- 16 sedentary overweight/obese men randomised 8 training/8 control; 12 weeks, 4 days/week, 45 minutes at 75–80% VO2max.
- Result
- Adiponectin mRNA and plasma increased; adiposity fell concurrently.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Adiponectin mRNA and plasma increased; adiposity fell concurrently.
- Limitations
- Transcription is not secretion or receptor responsiveness. Small sample; weight-independent mediation and optimal exercise dose not established.
- Evidence Source
- Bounded external search
- Reference
- [44]
- Study
- 25 sedentary women with obesity; 12-week aerobic programme, 5 days/week at 50% VO2max; biopsy subgroup 8.
- Population
- 25 sedentary women with obesity; 12-week aerobic programme, 5 days/week at 50% VO2max; biopsy subgroup 8.
- Result
- No significant changes in tested tissue transcripts; plasma leptin fell, plasma adiponectin unchanged, despite weight/fat loss.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- No significant changes in tested tissue transcripts; plasma leptin fell, plasma adiponectin unchanged, despite weight/fat loss.
- Limitations
- Small biopsy subgroup; uncontrolled pre/post design. Important contextual null, not direct refutation of a different acute interstitial measurement.
- Evidence Source
- Bounded external search
- Reference
- [45]
Not scored · Evidence & Audit
Defined EPA and DHA exposures increased adiponectin secretion in cultured human adipocytes; oral fish-oil trials show heterogeneous circulating responses without establishing the same local secretory mechanism.
What this means
The cell experiment used 100 µM free fatty acid for 48 hours and measured secreted protein. The fish-oil meta-analysis concerns circulating concentrations, includes substantial heterogeneity and loses a clear effect after publication-bias adjustment; fish-feeding evidence did not establish an increase. The secondary synthesis is not an independent cell experiment.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F18
Finding Statement: Defined EPA and DHA exposures increased adiponectin secretion in cultured human adipocytes; oral fish-oil trials show heterogeneous circulating responses without establishing the same local secretory mechanism.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: The cell experiment used 100 µM free fatty acid for 48 hours and measured secreted protein. The fish-oil meta-analysis concerns circulating concentrations, includes substantial heterogeneity and loses a clear effect after publication-bias adjustment; fish-feeding evidence did not establish an increase. The secondary synthesis is not an independent cell experiment.
Synthesis Limitations: No equivalence between cultured exposure, supplement formulations and ordinary fish foods is established. PPARγ and drug-combination results do not establish dietary synergy. A missing essential delivery-and-engagement bridge is not repaired by a Low confidence label.
Evidence Considered:
- Study
- Isolated cultured human adipocytes exposed for 48 hours to 100 µM free EPA or DHA, with PPARγ perturbation and rosiglitazone comparisons.
- Population
- Isolated cultured human adipocytes exposed for 48 hours to 100 µM free EPA or DHA, with PPARγ perturbation and rosiglitazone comparisons.
- Result
- Adiponectin secretion rose 88% with EPA and 47% with DHA; antagonist responses differed.
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Adiponectin secretion rose 88% with EPA and 47% with DHA; antagonist responses differed.
- Limitations
- Cultured free-fatty-acid exposure is not dietary delivery. Rosiglitazone is pharmacological; no ordinary-fish, food-dose or clinical equivalence.
- Evidence Source
- Bounded external search
- Reference
- [46]
- Study
- Systematic review/meta-analysis: 14 fish-oil trial arms, 682 intervention/641 control; two fish-feeding arms separately.
- Population
- Systematic review/meta-analysis: 14 fish-oil trial arms, 682 intervention/641 control; two fish-feeding arms separately.
- Result
- Fish-oil pooled +0.37 µg/mL (95% CI 0.07–0.67), substantial heterogeneity; publication-bias adjustment +0.18 (−0.15 to 0.52). Fish-feeding estimate −0.01 (−0.65 to 0.64).
- Effect / Magnitude
- Only the explicitly verified numerical results in this source assessment are claimed; no unverified confidence interval or food-effective dose is supplied.
- Evidence Summary
- Fish-oil pooled +0.37 µg/mL (95% CI 0.07–0.67), substantial heterogeneity; publication-bias adjustment +0.18 (−0.15 to 0.52). Fish-feeding estimate −0.01 (−0.65 to 0.64).
- Limitations
- Secondary synthesis; do not double-count included trials. Blood concentration does not identify secretion mechanism; heterogeneous formulations and publication bias limit coherence.
- Evidence Source
- Bounded external search
- Reference
- [47]
Not scored · Evidence & Audit
Defined oral DHA exposures altered circulating adiponectin in selected human intervention contexts; mixed marine-omega-3 and enriched-oil responses do not establish adipose secretion or ordinary-food equivalence.
What this means
The DHA-versus-EPA crossover provides substance-specific evidence of a circulating adipose-derived endocrine signal response. Gammelmark demonstrates oral mixed-fatty-acid delivery and adipose incorporation; Baril-Gravel tests an enriched oil diet, not isolated DHA. Rausch preserves heterogeneous and null trials rather than counting favourable directions as proof. Circulating signal modulation is the admitted scope; synthesis, secretion and receptor responsiveness remain unmeasured.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F19
Finding Statement: Defined oral DHA exposures altered circulating adiponectin in selected human intervention contexts; mixed marine-omega-3 and enriched-oil responses do not establish adipose secretion or ordinary-food equivalence.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: The DHA-versus-EPA crossover provides substance-specific evidence of a circulating adipose-derived endocrine signal response. Gammelmark demonstrates oral mixed-fatty-acid delivery and adipose incorporation; Baril-Gravel tests an enriched oil diet, not isolated DHA. Rausch preserves heterogeneous and null trials rather than counting favourable directions as proof. Circulating signal modulation is the admitted scope; synthesis, secretion and receptor responsiveness remain unmeasured.
Synthesis Limitations: Supplement/enriched-oil exposures, selected populations and heterogeneous trials limit extrapolation. No universal benefit from higher adiponectin, isolated EPA effect, ordinary-fish efficacy, effective food dose or brain/ADHD effect established. Some primary full methods and supplements remain unavailable; review-table bias judgments are not independent primary verification.
Evidence Considered:
- Study
- 154 adults randomised in double-blind crossover; 2.7 g/day EPA, 2.7 g/day DHA (90%-pure re-esterified triglyceride supplements), or corn oil for 10 weeks, 9-week washouts.
- Population
- 154 adults randomised in double-blind crossover; 2.7 g/day EPA, 2.7 g/day DHA (90%-pure re-esterified triglyceride supplements), or corn oil for 10 weeks, 9-week washouts.
- Result
- DHA increased adiponectin more than EPA: +3.1% ±1.6% versus −1.2% ±1.7%, P<0.001 in primary abstract; Rausch reports DHA-control contrast.
- Effect / Magnitude
- DHA increased adiponectin more than EPA: +3.1% ±1.6% versus −1.2% ±1.7%, P<0.001 in primary abstract; Rausch reports DHA-control contrast.
- Evidence Summary
- DHA-specific oral exposure and endocrine signal modulation support the bounded Type B proposition. This is not evidence for tissue secretion or general improvement.
- Limitations
- No adipose secretion/receptor assay; selected population and supplement form; no ordinary-food, dose-equivalence or clinical benefit inferred.
- Evidence Source
- Bounded external search
- Reference
- [68]
- Study
- 50 overweight adults randomised double-blind to 2 g/day fish oil (1.1 g marine n-3) or 2 g olive oil for 6 weeks; day-1 assessment.
- Population
- 50 overweight adults randomised double-blind to 2 g/day fish oil (1.1 g marine n-3) or 2 g olive oil for 6 weeks; day-1 assessment.
- Result
- Adiponectin difference +0.55 µg/mL (95% CI 0.02–1.08); adipose n-3 incorporation increased. No overall anti-inflammatory effect.
- Effect / Magnitude
- Adiponectin difference +0.55 µg/mL (95% CI 0.02–1.08); adipose n-3 incorporation increased. No overall anti-inflammatory effect.
- Evidence Summary
- Oral delivery is demonstrated for the mixture. Previous blanket missing-delivery wording was too broad; local secretory mediation still unmeasured.
- Limitations
- Incorporation is not secretion. Mixed EPA/DHA does not isolate EPA versus DHA; small effect, adiposity/clearance mediation unresolved.
- Evidence Source
- Bounded external search
- Reference
- [64]
- Study
- 114 adults with abdominal obesity plus another metabolic-syndrome criterion; five isoenergetic 4-week diet periods with 4-week washouts; oils 60 g/3000 kcal.
- Population
- 114 adults with abdominal obesity plus another metabolic-syndrome criterion; five isoenergetic 4-week diet periods with 4-week washouts; oils 60 g/3000 kcal.
- Result
- DHA-enriched high-oleic canola oil: +4.5% versus corn/safflower, +6.9% versus flax/safflower.
- Effect / Magnitude
- DHA-enriched high-oleic canola oil: +4.5% versus corn/safflower, +6.9% versus flax/safflower.
- Evidence Summary
- Attributable exposure is the tested oil diet. DHA-specific admission additionally relies on the separate ComparED trial, not this formulation alone.
- Limitations
- Published significant contrasts do not isolate DHA from the high-oleic carrier; no claimed superiority to every canola arm or generic oil/food equivalent.
- Evidence Source
- Bounded external search
- Reference
- [65]
- Study
- 31 RCTs, varied EPA/DHA doses, populations and duration; searches to June 2018.
- Population
- 31 RCTs, varied EPA/DHA doses, populations and duration; searches to June 2018.
- Result
- 18/31 reported lower leptin or higher adiponectin direction; 9 significant between-group results. Review did not pool effect sizes because distribution/reporting differed.
- Effect / Magnitude
- 18/31 reported lower leptin or higher adiponectin direction; 9 significant between-group results. Review did not pool effect sizes because distribution/reporting differed.
- Evidence Summary
- Supports recovery of primary trials and limits generalisation; no class-wide admission by vote count.
- Limitations
- Secondary synthesis, not 31 independent confirmations of one formulation. Primary trial overlap retained; dose and population variability preclude universal efficacy.
- Evidence Source
- Bounded external search
- Reference
- [63]
Not scored · Evidence & Audit
Supports SOP: Milled flaxseed in the studied balanced-diet protocol
A 12-week milled-flaxseed trial in overweight or obese women reported a circulating adiponectin difference, while broader pooled evidence was heterogeneous and did not establish an overall adiponectin effect.
What this means
The tested food was milled whole flaxseed with a balanced diet, not isolated ALA, lignan or fibre. The primary report analysed 52 completers after differential dropout and concurrent weight/waist changes. Its leptin between-group contrast was not significant. The later synthesis qualifies generalisation and is not an independent trial replication.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F20
Finding Statement: A 12-week milled-flaxseed trial in overweight or obese women reported a circulating adiponectin difference, while broader pooled evidence was heterogeneous and did not establish an overall adiponectin effect.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: The tested food was milled whole flaxseed with a balanced diet, not isolated ALA, lignan or fibre. The primary report analysed 52 completers after differential dropout and concurrent weight/waist changes. Its leptin between-group contrast was not significant. The later synthesis qualifies generalisation and is not an independent trial replication.
Synthesis Limitations: Food/form/population-specific physiological response; weight-independent mediation, adipose secretion and active constituent are unresolved. No universal hormone target, clinical or brain benefit inferred. Small-study effects and pooled uncertainty remain visible.
Evidence Considered:
- Study
- 60 women aged 25–50 randomised to balanced diet plus 30 g/day milled brown flaxseed or raw milled rice for 12 weeks.
- Population
- 60 women aged 25–50 randomised to balanced diet plus 30 g/day milled brown flaxseed or raw milled rice for 12 weeks.
- Result
- 52 completed (29 flax/23 control). Higher adiponectin between groups; leptin contrast not significant. Weight and waist also changed.
- Effect / Magnitude
- 52 completed (29 flax/23 control). Higher adiponectin between groups; leptin contrast not significant. Weight and waist also changed.
- Evidence Summary
- A defined human food protocol measured an endocrine signal. Admission is limited to studied circulating response, not weight-independent mechanism or universal optimisation.
- Limitations
- Differential attrition, complete-case analysis and concurrent weight change; no constituent attribution or proven secretory mechanism. Adiponectin units retained as printed.
- Evidence Source
- Bounded external search
- Reference
- [66]
- Study
- 13 RCTs/15 arms, varied whole/ground flaxseed and oils; searches through December 2022.
- Population
- 13 RCTs/15 arms, varied whole/ground flaxseed and oils; searches through December 2022.
- Result
- Pooled adiponectin was not significant; substantial heterogeneity and small-study effects. Whole-flax subgroup differed from oils.
- Effect / Magnitude
- Pooled adiponectin was not significant; substantial heterogeneity and small-study effects. Whole-flax subgroup differed from oils.
- Evidence Summary
- Retain positive study and pooled uncertainty together; no duplicate independent replication credit.
- Limitations
- Secondary synthesis overlaps primary trial. Subgroup findings cannot erase overall uncertainty; no full-class or isolated-ALA effect inferred.
- Evidence Source
- Bounded external search
- Reference
- [69]
Mechanistic explanation: Milled flaxseed has a bounded circulating adiponectin trial signal
Not scored · Evidence & Audit
A soluble-fibre meta-analysis did not establish significant overall changes in circulating leptin or adiponectin and reported substantial between-study heterogeneity.
What this means
The overall estimates include no-effect values; subtype and subgroup findings do not validate a generic fibre endocrine claim. This is a secondary synthesis of trials, not a primary experiment or proof that every fibre is inactive.
Evidence confidence: Not scored · Evidence & Audit
Finding ID: PM8-F21
Finding Statement: A soluble-fibre meta-analysis did not establish significant overall changes in circulating leptin or adiponectin and reported substantial between-study heterogeneity.
Synthesised Evidence Confidence: Not scored · Evidence & Audit
Synthesis: The overall estimates include no-effect values; subtype and subgroup findings do not validate a generic fibre endocrine claim. This is a secondary synthesis of trials, not a primary experiment or proof that every fibre is inactive.
Synthesis Limitations: Heterogeneous preparations, populations and subgroup analyses; blood concentrations do not identify local secretion, receptor effects or microbial mediation. Other-BRS benefits do not establish PM8 engagement.
Evidence Considered:
- Study
- Systematic review/dose-response meta-analysis of soluble-fibre supplementation; searches through December 2021.
- Population
- Systematic review/dose-response meta-analysis of soluble-fibre supplementation; searches through December 2021.
- Result
- Overall adiponectin SMD −0.49 (95% CI −1.20,0.21), leptin −0.80 (−1.70,0.08); high heterogeneity.
- Effect / Magnitude
- Overall adiponectin SMD −0.49 (95% CI −1.20,0.21), leptin −0.80 (−1.70,0.08); high heterogeneity.
- Evidence Summary
- No generic fibre Type A/B admission; cross-BRS benefits are not PM8 endocrine engagement.
- Limitations
- Overall null is not proof of no effect. Borderline subgroup signals, heterogeneous preparations and dose modelling do not establish a generic PM8 fibre relationship.
- Evidence Source
- Bounded external search
- Reference
- [67]
5. BRS Pathways and Connections
5.1 BRS Pathways
Peripheral endocrine communication contributes to metabolic–endocrine adaptation. No whole-body resource-allocation mechanism is inferred.
5.2 Cross-BRS Mechanism Relationships
BRS3 inflammatory regulation can influence adipose endocrine conditions, but inflammation is not this PM’s defining operation. No new causal graph or brain-outcome relationship is admitted.
5.3 Local BRS Mechanism Relationships
Insulin Sensitivity & Glucose Disposal addresses insulin-responsive disposal; Cortisol Rhythm Regulation addresses systemic timing. Stress-Modulated Appetite & Reward Regulation addresses central appetite/reward integration, not adipokine production.
7. Phenome Connections
These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.
Each Phenome relationship has two independent ratings. They are not combined or averaged.
Biology → Phenome Relationship Strength
How direct and important is this biological mechanism expected to be to the Phenome within the BRAIN model?
Evidence Confidence
How strongly does the adjudicated evidence support this particular biology → Phenome relationship?
No direct functional outcome relationship currently mapped.
8. References
- [1] Mohammad & Thiemermann (2021) — Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
- [2] Cazzola et al. (2024) — A Defense Line to Mitigate Inflammation and Oxidative Stress in Adipose Tissue
- [3] Kiecolt-Glaser et al. (2011) — Omega-3 supplementation lowers inflammation and anxiety in medical students: a randomized controlled trial
- [4] Di Girolamo et al. (2022) — Prevalence of Metabolic Syndrome and Insulin Resistance in a Sample of Adult
- [5] Marcelli et al. (2025) — Insights Into Shared Mechanisms and Clinical Implications
- [6] Magkos et al. (2016) — Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity
- [7] Zelicha et al. (2022) — The effect of high-polyphenol Mediterranean diet on visceral adiposity: the DIRECT PLUS randomized controlled trial
- [8] Zelicha et al. (2024) — Altered proteome profiles related to visceral adiposity may mediate the favorable effect of green Mediterranean diet: the DIRECT-PLUS trial
- [9] Njike et al. (2015) — Walnut ingestion in adults at risk for diabetes: effects on body composition, diet quality, and cardiac risk measures
- [10] Dong et al. (2026) — Effect of a walnut-based low carbohydrate diet on fat redistribution and visceral fat accumulation in people with central obesity: A randomized controlled trial
- [11] Nagao et al. (2007) — A green tea extract high in catechins reduces body fat and cardiovascular risks in humans
- [12] Iino et al. (2026) — Green Tea Catechin Plus Inulin Improves Insulin Resistance Without Reducing Visceral Fat and Shows Exploratory Gut Microbiota Signals in Adults with Visceral Obesity: A Double-Blind Randomized Controlled Trial
- [13] Spencer et al. (2013) — Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance
- [14] Fisk et al. (2022) — Modification of subcutaneous white adipose tissue inflammation by omega-3 fatty acids is limited in human obesity—a double blind, randomised clinical trial
- [15] Weisberg et al. (2003) — Obesity is associated with macrophage accumulation in adipose tissue
- [16] Boden et al. (2015) — Excessive caloric intake acutely causes oxidative stress, GLUT4 carbonylation, and insulin resistance in healthy men
- [17] Kurstjens et al. (2018) — Magnesium deficiency prevents high-fat-diet-induced obesity in mice
- [18] Ahn et al. (2022) — Exercise training remodels subcutaneous adipose tissue in adults with obesity even without weight loss
- [19] Covassin et al. (2022) — Effects of Experimental Sleep Restriction on Energy Intake, Energy Expenditure, and Visceral Obesity
- [20] Wilkinson et al. (2026) — Time-Restricted Eating Promotes Weight Loss and Favorable Changes in Adipose in Obesity: The TREAD Randomized Control Trial
- [21] Dote-Montero et al. (2025) — Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial
- [22] Hames et al. (2017) — Very-long-chain omega-3 fatty acid supplements and adipose tissue functions: a randomized controlled trial
- [23] Willmann et al. (2019) — Potential effects of reduced red meat compared with increased fiber intake on glucose metabolism and liver fat content: a randomized and controlled dietary intervention study
- [24] Park et al. (2014) — Pomegranate vinegar beverage reduces visceral fat accumulation in association with AMPK activation in overweight women: A double-blind, randomized, and placebo-controlled trial
- [25] de Kloet et al. (2015) — Adipocyte glucocorticoid receptors mediate fat-to-brain signaling
- [26] de Kloet & Herman (2018; online 2017) — Fat-brain connections: Adipocyte glucocorticoid control of stress and metabolism
- [27] Scheja & Heeren (2019) — The endocrine function of adipose tissues in health and cardiometabolic disease
- [28] Tsuji & Tseng (2026) — Adipose tissue as a humoral-neuronal hub in metabolic regulation
- [29] Sandeep et al. (2005) — Increased in vivo regeneration of cortisol in adipose tissue in human obesity and effects of the 11beta-hydroxysteroid dehydrogenase type 1 inhibitor carbenoxolone
- [30] Lee et al. (2007) — Acute and chronic regulation of leptin synthesis, storage, and secretion by insulin and dexamethasone in human adipose tissue
- [31] Degawa-Yamauchi et al. (2005) — Regulation of adiponectin expression in human adipocytes: effects of adiposity, glucocorticoids, and tumor necrosis factor alpha
- [32] Stimson et al. (2007) — Dietary macronutrient content alters cortisol metabolism independently of body weight changes in obese men
- [33] Tomlinson et al. (2004) — Weight loss increases 11beta-hydroxysteroid dehydrogenase type 1 expression in human adipose tissue
- [34] Trepanowski et al. (2018; online 2017) — Effects of alternate-day fasting or daily calorie restriction on body composition, fat distribution, and circulating adipokines: Secondary analysis of a randomized controlled trial
- [35] Ma et al. (2016) — Weight-Loss Diets, Adiponectin, and Changes in Cardiometabolic Risk in the 2-Year POUNDS Lost Trial
- [36] Fallo et al. (2004) — Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome
- [37] Moghadasi et al. (2013; online 2011) — Effects of short-term lifestyle activity modification on adiponectin mRNA expression and plasma concentrations
- [38] Patel et al. (2006) — Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment
- [39] You et al. (2014) — Regional adipose tissue hormone/cytokine production before and after weight loss in abdominally obese women.
- [40] Arvidsson et al. (2004) — Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women.
- [41] Siklova-Vitkova et al. (2012) — Adipose tissue secretion and expression of adipocyte-produced and stromavascular fraction-produced adipokines vary during multiple phases of weight-reducing dietary intervention in obese women.
- [42] Klein et al. (2000) — Leptin production during early starvation in lean and obese women.
- [43] Højbjerre et al. (2007) — Acute exercise increases adipose tissue interstitial adiponectin concentration in healthy overweight and lean subjects.
- [44] Moghadasi et al. (2012) — High-intensity endurance training improves adiponectin mRNA and plasma concentrations.
- [45] Polak et al. (2006) — Effect of aerobic training on plasma levels and subcutaneous abdominal adipose tissue gene expression of adiponectin, leptin, interleukin 6, and tumor necrosis factor alpha in obese women.
- [46] Tishinsky et al. (2011) — Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes.
- [47] Wu et al. (2013) — Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials.
- [48] Stomby et al. (2015) — Diet-induced weight loss has chronic tissue-specific effects on glucocorticoid metabolism in overweight postmenopausal women.
- [49] Evans et al. (2001) — Carbohydrate and fat have different effects on plasma leptin concentrations and adipose tissue leptin production.
- [50] Weigle et al. (2005) — A high-protein diet induces sustained reductions in appetite, ad libitum caloric intake, and body weight despite compensatory changes in diurnal plasma leptin and ghrelin concentrations.
- [51] Vujović et al. (2022) — Late isocaloric eating increases hunger, decreases energy expenditure, and modifies metabolic pathways in adults with overweight and obesity.
- [52] Ravussin et al. (2019) — Early Time-Restricted Feeding Reduces Appetite and Increases Fat Oxidation But Does Not Affect Energy Expenditure in Humans.
- [53] Wehrens et al. (2017) — Meal Timing Regulates the Human Circadian System.
- [54] Polito et al. (2020) — Nutritional factors influencing plasma adiponectin levels: results from a randomised controlled study with whole-grain cereals.
- [55] Behrouz et al. (2017) — Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial.
- [56] Reddy et al. (2023) — Adherence to a Mediterranean diet may improve serum adiponectin in adults with nonalcoholic fatty liver disease: The MEDINA randomized controlled trial.
- [57] Fatouros et al. (2005) — Leptin and adiponectin responses in overweight inactive elderly following resistance training and detraining are intensity related.
- [58] Mansouri et al. (2011) — The impact of one session resistance exercise on plasma adiponectin and RBP4 concentration in trained and untrained healthy young men.
- [59] Spiegel et al. (2004) — Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite.
- [60] Capers et al. (2015) — A systematic review and meta-analysis of randomized controlled trials of the impact of sleep duration on adiposity and components of energy balance.
- [61] Broussard et al. (2012) — Impaired insulin signaling in human adipocytes after experimental sleep restriction: a randomized, crossover study.
- [62] Westphal et al. (2007) — Extended-release niacin raises adiponectin and leptin.
- [63] Rausch et al. (2021) — Systematic review of marine-derived omega-3 fatty acid supplementation effects on leptin, adiponectin, and the leptin-to-adiponectin ratio.
- [64] Gammelmark et al. (2012) — Low-dose fish oil supplementation increases serum adiponectin without affecting inflammatory markers in overweight subjects.
- [65] Baril-Gravel et al. (2015) — Docosahexaenoic acid-enriched canola oil increases adiponectin concentrations: a randomized crossover controlled intervention trial.
- [66] Ahmadniay Motlagh et al. (2021) — Effect of flaxseed consumption on central obesity, serum lipids, and adiponectin level in overweight or obese women: A randomised controlled clinical trial.
- [67] Zeinabi et al. (2023) — Soluble Fiber Effect on Human Serum Leptin and Adiponectin: A Systematic Review and Dose-Response Meta-Analysis.
- [68] Allaire et al. (2016) — A randomized, crossover, head-to-head comparison of eicosapentaenoic acid and docosahexaenoic acid supplementation to reduce inflammation markers in men and women: the Comparing EPA to DHA (ComparED) Study.
- [69] Abbasi et al. (2023) — Can flaxseed supplementation affect circulating adipokines in adults? An updated systematic review and meta-analysis of randomized controlled trials.
No validated structured conversion route is currently projected for this PM. This does not remove or reclassify its existing dietary inputs.
Mapping state: admitted-food-targets-resolved.